Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Darren S. Heeke"'
Autor:
Jason D Marshall, Darren S Heeke, Eileen Rao, Sean K Maynard, David Hornigold, Christopher McCrae, Neil Fraser, Andrey Tovchigrechko, Li Yu, Nicola Williams, Sarah King, Martin E Cooper, Adeline M Hajjar, Jennifer C Woo
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164632 (2016)
The best-characterized Toll-like receptor 4 (TLR4) ligands are lipopolysaccharide (LPS) and its chemically modified and detoxified variant, monophosphoryl lipid A (MPL). Although both molecules are active for human TLR4, they demonstrate a potency pr
Externí odkaz:
https://doaj.org/article/a7e51b143f2f4c90835b58966e433abe
Autor:
Derek D. Sloan, Roselyn J. Eisenberg, Padmaja Tummala, Michael T Hensel, Jason D. Marshall, Darren S. Heeke, Eileen Rao, Michael R Dorwart, Gary H. Cohen, Li Yu
Several prophylactic vaccines targeting herpes simplex virus 2 (HSV-2) have failed in the clinic to demonstrate sustained depression of viral shedding or protection from recurrences. Although these vaccines have generated high titers of neutralizing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c75276a45dbd801a696c7aae5187fab2
https://europepmc.org/articles/PMC5391472/
https://europepmc.org/articles/PMC5391472/
Autor:
Jason D. Marshall, Rui Lin, Michael P. McCarthy, Vera Chio, Darren S. Heeke, Li Yu, Hui Liu, Eileen Rao, Fengrong Zuo, Floro Cataniag
Publikováno v:
Journal of virological methods. 247
The goal of most prophylactic vaccines is to elicit robust and effective neutralizing antibodies against the human pathogen target. The titer of neutralizing antibodies to Epstein-Barr Virus (EBV) is a useful biomarker for evaluating EBV vaccines. He
Autor:
Cooper Martin, Darren S. Heeke, Jason D. Marshall, Adeline M. Hajjar, Sarah King, Nicola Williams, Christopher McCrae, Jennifer Woo, Andrey Tovchigrechko, Neil Fraser, Li Yu, Eileen Rao, David C. Hornigold, Sean K. Maynard
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 10, p e0164632 (2016)
PLoS ONE, Vol 11, Iss 10, p e0164632 (2016)
The best-characterized Toll-like receptor 4 (TLR4) ligands are lipopolysaccharide (LPS) and its chemically modified and detoxified variant, monophosphoryl lipid A (MPL). Although both molecules are active for human TLR4, they demonstrate a potency pr
Publikováno v:
Vaccine. 34(23)
Childhood infection with Epstein-Barr virus (EBV) is often asymptomatic and may result in mild flu-like symptoms, but exposure during adolescence and young adulthood can lead to acute infectious mononucleosis (AIM) with a pathology characterized by s
Autor:
Chris Frantz, Rui Lin, Fengrong Zuo, Kathryn Patton, Shahin Aslam, Xavier Paliard, Stacie L. Lambert, Darren S. Heeke, Mark T. Esser, Cindy Shambaugh
Publikováno v:
Vaccine. 33(36)
Respiratory syncytial virus (RSV) causes significant disease in elderly adults, but an effective vaccine is not yet available. We have previously reported that vaccines consisting of engineered respiratory syncytial virus soluble fusion protein (RSV
Publikováno v:
Immunology. 117:38-46
Immunostimulatory sequences (ISS) that contain CpG motifs have been demonstrated to exert antipathogen and antitumour immunity in animal models through several mechanisms, including the activation of natural killer (NK) cells to secrete interferon-ga
Autor:
Jason Marshall, Marianne L Gesner, Gary Van Nest, Brian S Livingston, Eduardo B. Martins, Darren S. Heeke
Publikováno v:
The FASEB Journal. 22
Publikováno v:
The FASEB Journal. 22
Publikováno v:
Journal of leukocyte biology. 82(3)
Toll-like receptors (TLRs) are a family of molecules that function as sensors for the detection of foreign pathogens through the recognition of nonvariable microbial motifs. Although numerous studies have focused on singular TLRs, less attention has